APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,316,184 | +211.2% | 34,600 | +458.7% | 0.01% | +180.0% |
| Q3 2022 | $423,000 | +54.4% | 6,193 | +2.2% | 0.01% | +66.7% |
| Q2 2022 | $274,000 | -65.3% | 6,060 | -61.0% | 0.00% | -57.1% |
| Q1 2022 | $790,000 | -86.5% | 15,549 | -87.4% | 0.01% | -84.8% |
| Q4 2021 | $5,839,000 | -35.8% | 123,490 | -55.2% | 0.05% | -35.2% |
| Q3 2021 | $9,094,000 | -18.9% | 275,910 | +55.4% | 0.07% | -13.4% |
| Q2 2021 | $11,220,000 | – | 177,525 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |